Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

La empresa local de secuenciación genética citó ahorros de costos para alinearse con su futura estrategia comercial.

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth ...

In a sign it is willing to go further in responding to President Trump’s tariffs, Beijing blocked more American companies ...

Over the past year, the shadow of the Grail deal has hung over Illumina despite its reinvigorated leadership and launch of ...

Illumina, Inc. (NASDAQ:ILMN) offers sequencing- and array-based solutions for genetic and genomic analysis. The one-month return of Illumina, Inc. (NASDAQ:ILMN) was -32.97%, and its shares lost 34 ...

The MiSeq desktop sequencer offers low throughput flowcells and long read lengths. It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The ...

The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...

“The speed and accuracy of SBX has the potential to revolutionise the use of sequencing in research and healthcare.” Illumina maps out entry into spatial transcriptomics Though the technology ...

At a launch event on Feb. 20, Roche detailed plans to enter Illumina's sequencing stronghold with a new platform. Roche's platform is in testing now and scheduled to launch commercially in 2026.

“In partnership with local enterprises such as Venture Corp and Sunningdale Tech, the facility manufactures the full range of Illumina’s products, such as the MiniSeq and MiSeq i100 genome sequencing ...

"In partnership with local enterprises such as Venture Corporation and Sunningdale Tech, the facility manufactures the full range of Illumina’s products, such as the MiniSeq and MiSeq i100 genome ...